
Kindling is the name for a pattern in which each abrupt withdrawal from a benzodiazepine can be harder than the one before it. Every cold stop, often called cold turkey, and every cycle of stopping and restarting, can leave the nervous system more reactive. So, the next withdrawal tends to arrive sooner, feel worse, and carry a higher risk of a seizure.
The word is borrowed from fire-building. Kindling is the small, dry wood that lets a fire catch fast. In this picture, each abrupt withdrawal leaves more dry wood behind, and the next spark catches sooner and burns hotter.
Kindling is not caused by a slow taper. It is tied to stopping suddenly, to cutting the dose too fast, and to doing so more than once. Yet, many people read about kindling and come away afraid of tapering, which is the one thing that protects them.
A reader who searches the Ashton Manual for the term will not find it. Professor C. Heather Ashton did not use the word in the Manual’s three chapters or in the supplement she added in 2011. The concept comes from clinical experience, and it fits the Manual’s repeated warning against abrupt withdrawal.
That warning is direct. Chapter II of the Manual states that abrupt or over-rapid withdrawal, especially from a high dose, can give rise to severe symptoms, including convulsions. It adds that withdrawing this way may increase the risk of protracted withdrawal symptoms.
Professor Ashton also came close to the idea itself. In the 2011 supplement, she wrote that going back to the original dose often does not work the second time, perhaps because the first experience of withdrawal has already sensitized the nervous system.
A benzodiazepine boosts the effect of gamma-aminobutyric acid (GABA), a chemical messenger that quiets nerve cells. With steady use, the brain adapts.
Chapter I of the Manual explains that the receptors become less responsive, which is how tolerance develops. The brain comes to depend on the drug to stay in balance.
When the drug is taken away quickly, the quieting drops out faster than the brain can readjust. Chapter III describes the result as rebound overactivity of the systems the drug had damped down.
Kindling is the idea that the rebound does not fully reset before the next one arrives. The exact mechanism has not been worked out for benzodiazepines, and the evidence is limited. Still, the pattern is one that patients describe again and again. The second abrupt stop is often worse than the first, and the third can be worse than the second.
The risk follows the number and the speed of earlier withdrawals. A prescription that was cut off, a supply that ran out, and a facility stay that ended a benzodiazepine in a week or two are each an abrupt withdrawal. Earlier tapers that moved too fast belong on the same list.
Alcohol counts as well. It acts on GABA receptors too, so repeated bouts of heavy drinking and sudden stopping can put the same system through the same cycle. Alcohol is best avoided during a taper.
A person who has stopped and restarted several times is often told that the pattern proves addiction. It does not. Physical dependence is not addiction.
In fact, the United States Food and Drug Administration (FDA) stated in its 2020 boxed-warning update that physical dependence can occur when a benzodiazepine is taken steadily for several days to weeks, even as prescribed. The addiction label is wrong, and it leads to the wrong treatment.
Fortunately, kindling is not a reason to fear tapering. A gradual taper is one slow withdrawal that the nervous system can keep pace with.
A hold is not a withdrawal attempt. Staying at the same dose for a few weeks, while symptoms settle or while life is demanding, is part of the plan. Chapter II of the Manual describes standing still for a few weeks when circumstances change.
What about going back up? The Manual prefers a hold to an increase. In Dr. Leeds’ practice, a small updose after a cut that proves too large can be a legitimate adjustment on a diazepam taper, decided case by case, though when clonazepam itself seems to be causing toxic symptoms his direction is a transition to diazepam or continuing the taper instead. It is different from stopping completely and starting over, which is the cycle that the word kindling describes.
Many people who search for a benzodiazepine detox are looking for a safe way off their medication. Safe discontinuation is a gradual, medically supervised taper over months, sometimes longer. What a facility usually offers is a taper measured in days or weeks, on a timeline set by insurance coverage, with the goal of being off the drug by discharge.
Chapter II of the Manual notes that withdrawal in a hospital or special center is usually fairly rapid, and that setbacks on returning home are common. The FDA’s 2020 update says that stopping abruptly or reducing the dosage too quickly can cause withdrawal reactions, including seizures, that can be life-threatening.
Kindling makes the case sharper. If each abrupt withdrawal leaves the nervous system more reactive, then a second or third fast facility withdrawal is not a fresh start. It is more dry wood on the pile.
Rapid benzodiazepine withdrawal is the harm that Dr. Leeds’ practice exists to prevent. A person with a history of hard withdrawals should never be put through another cold stop. That person needs one slow taper, with holds, in which the medication is never stopped and restarted.
The first step is to stop the cycle. For a person who is still taking a benzodiazepine, that means settling on a steady dose under a physician’s supervision for a set period, usually a couple of weeks, agreed with the physician rather than an open-ended wait for symptoms to calm. No reductions happen during this time.
Then, the taper starts again, slower than before. Chapter II of the Manual describes reductions of up to one tenth of the dose at each step, with the patient in control of the schedule. The Maudsley Deprescribing Guidelines describe hyperbolic tapering, in which each reduction becomes smaller as the dose gets lower.
For a sensitized nervous system, the usual adjustment is smaller steps and longer waits between them. The pace belongs to the patient, and if a step is too hard, the physician must slow the plan down.
No medication has been shown to prevent kindling or to undo it. The protection lies in how the benzodiazepine itself is reduced.
A hard history does not close the door. Chapter II says that people who need a second try have usually been withdrawn too quickly the first time, and speed can be changed.
A person who has already stopped abruptly and is in withdrawal now is in a different position. Whether and how to restart is a medical decision, and it belongs in a prompt conversation with a physician.
It evens out the daily rise and fall of the drug. Chapter II of the Manual says that with relatively short-acting benzodiazepines, such as alprazolam (Xanax) and lorazepam (Ativan), it is not possible to achieve a smooth decline in blood and tissue concentrations.
The Manual’s answer is the crossover taper, a gradual, stepwise switch to diazepam (Valium) guided by the equivalence table in Chapter I. Diazepam is eliminated slowly, which allows a smooth, gradual fall in blood level.
Of course, the crossover is not required. Some people do well tapering the medication they already take, and the decision to switch to diazepam is made with the patient.
The difference is time. Acute withdrawal is the rebound that follows a reduction, and for most people it fades as the nervous system readjusts. Protracted withdrawal is the name for symptoms that continue long after the last dose.
Chapter III of the Manual describes a minority of people whose symptoms last for months or even years. Professor Ashton observed that many of them had taken benzodiazepines for twenty years or more, had bad experiences in withdrawal, or both. She added that protracted symptoms are almost certainly much less common after a slow taper under the patient’s own control.
Abrupt withdrawal is the common thread behind kindling, behind the worst acute symptoms, and possibly behind protracted withdrawal as well. Even then, the Manual says that a steady decline in symptoms almost always continues, though it can take a long time.
A seizure is an emergency, and it is the most serious risk of abrupt benzodiazepine withdrawal. Chapter III says that rapid withdrawal, especially from high-potency benzodiazepines, can bring on epileptic fits as a rebound reaction. It also says that this is extremely rare with slow dosage tapering or with slowly eliminated drugs such as diazepam.
Call 911 for a seizure, or for any other medical emergency. A person who is in crisis or thinking about suicide can call or text 988, the Suicide and Crisis Lifeline.
However, most warnings are quieter. In clinical experience, a reaction far out of proportion to the size of a reduction, symptoms clearly stronger than after earlier cuts of the same size, and new tremor, muscle jerks, or surges of panic are all worth reporting to the physician before the next step.
The response to an early warning is a hold and a conversation with the physician. It is never a faster exit.
No. There is no blood test, scan, questionnaire, or rating scale that diagnoses kindling. It is recognized from a person’s history of withdrawals and from how the body answers each change in dose.
No. Interdose withdrawal is the return of symptoms between doses as a short-acting drug wears off. Tolerance withdrawal is the appearance of symptoms on a steady dose. Kindling builds across repeated abrupt withdrawals, and all three can occur in the same person.
No one has shown that it is, and the evidence either way is limited. Clinical experience is that a sensitized nervous system settles with a steady dose, time, and a taper slow enough to tolerate, though no one can promise how long that takes.
Kindling is a warning about how a benzodiazepine is stopped. It is not a judgment of the person who has to stop it. With a steady dose, time, and a plan that is not rushed, the taper can still be finished.
Dr. Leeds’ practice offers medically supervised benzodiazepine and z-drug tapering for patients in Florida. Each taper is gradual and patient-directed, planned over months and sometimes longer, and built around the patient’s history, including every earlier withdrawal. Contact the office to ask about a taper planned around that history.
This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.

Mark Leeds, D.O. is an osteopathic physician and deprescribing specialist in Fort Lauderdale, Florida. He helps patients come off benzodiazepines and sleeping pills with a slow, patient-directed taper guided by the Ashton Manual and the Maudsley Deprescribing Guidelines. Physical dependence is not addiction, and a careful taper is measured in months, not days.
Contact the office today to ask about a slow, medically supervised benzodiazepine taper.





